Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Janet E. Pop"'
Autor:
Peter C. Taylor, Eugen Feist, Janet E. Pope, Peter Nash, Jean Sibilia, Roberto Caporali, Alejandro Balsa
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 16 (2024)
Rheumatoid arthritis (RA) is an autoimmune disease characterised by persistent inflammation of the synovial joints as well as other tissues and organs. Left untreated, it can lead to joint damage, disability and even increased mortality. The disease
Externí odkaz:
https://doaj.org/article/d96feea0ed454c218a7683db71ca7baa
Autor:
Stanford L. Peng, Kristan D. Rollins, Robert Spiera, Robert W. Simms, Dinesh Khanna, John Varga, Virginia D. Steen, Maureen D. Mayes, Fredrick M. Wigley, Naomi F. Rothfield, Barri J. Fessler, Bashar Kahaleh, Lorinda Chung, Richard M. Silver, David H. Collier, Elena Schiopu, Robyn T. Domsic, Soumya Chatterjee, Michael Wade, Christopher P. Denton, Murray Baron, Kevin Laliberte, Jerry A. Molitor, Mary Ellen Csuka, Vivien Hsu, Thomas A. Medsger, James R. Seibold, Ariane L. Herrick, Tracy M. Frech, Janet E. Pop
Publikováno v:
Journal of Scleroderma and Related Disorders. 2:42-49
Background Prostacyclins are routinely used to treat vascular features of systemic sclerosis (SSc, scleroderma) but require parenteral infusion or inhalation. This study evaluated the safety and efficacy of oral treprostinil in digital ulcers seconda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f329b590b00a7e62256e454c6e4260a
https://doi.org/10.5301/jsrd.5000232
https://doi.org/10.5301/jsrd.5000232
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 4, Pp 173-179 (2023)
Objective To describe the pattern and risk factors for antimalarial (AM)‐induced retinopathy in patients with rheumatic diseases. Methods A retrospective chart review was conducted at an urban Canadian center for patients with AM use of more than 3
Externí odkaz:
https://doaj.org/article/08d7e5e530cb42018b427a4d99095f2b
Autor:
Janet E. Pope, Yvonne C. Lee, Jeffrey R. Curtis, Daojun Mo, Li Xie, Christina L. Dickson, Douglas E. Schlichting, Anabela Cardoso, Lee S. Simon, Peter C. Taylor
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 3, Pp 254-258 (2022)
Objective Pain reduction with baricitinib was assessed in patients with rheumatoid arthritis (RA) who either used opioids or did not use opioids during three randomized, double‐blind phase 3 trials. Methods Analysis populations were as follows: i)
Externí odkaz:
https://doaj.org/article/86a87bdaa02641a29f900d98f08520ca
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The pathogenesis of connective tissue diseases (CTDs), such as systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), is characterized by derangements of the innate and adaptive immune system, and inflammatory pathways leading to autoimmuni
Externí odkaz:
https://doaj.org/article/a771f5333549467a8a039521ea6c2d88
Autor:
Kaleb Michaud, Janet E. Pope, Paul Emery, Baojin Zhu, Carol L. Gaich, Amy M. DeLozier, Xiang Zhang, Christina L. Dickson, Josef S. Smolen
Publikováno v:
Rheumatology and Therapy, Vol 6, Iss 3, Pp 409-419 (2019)
Abstract Introduction To explore the relationship of pain and fatigue with daily activity and work productivity in rheumatoid arthritis (RA) patients from the baricitinib clinical trial, RA-BEAM. Methods In RA-BEAM, a double-blind phase 3 study, pati
Externí odkaz:
https://doaj.org/article/8cacdf64500b41d186f04a8d38da63dc
Autor:
Janet E. Pope, Edward Keystone, Shahin Jamal, Lisy Wang, Lara Fallon, John Woolcott, Irina Lazariciu, Douglass Chapman, Boulos Haraoui
Publikováno v:
ACR Open Rheumatology, Vol 1, Iss 2, Pp 73-82 (2019)
ABSTRACT Objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This post hoc analysis evaluated tofacitinib persistence in patients with RA in long‐term extension (LTE) studies up to 9.5 years. Meth
Externí odkaz:
https://doaj.org/article/10a7f160ef4a4bb2979891238ac01951
Autor:
Sindhu R. Johnson, Frank van den Hoogen, Keshini Devakandan, Marco Matucci-Cerinic, Janet E. Pope
Publikováno v:
European Journal of Rheumatology, Vol 7, Iss -3, Pp S222-S227 (2020)
Externí odkaz:
https://doaj.org/article/805f1cd3571f43ed8460961fd879bb99
Autor:
Janet E. Pope
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-3 (2017)
Abstract One in six patients with systemic sclerosis will develop pulmonary arterial hypertension (PAH). Screening with echocardiography and possibly pulmonary function testing (to determine the diffusing capacity of carbon monoxide) is recommended t
Externí odkaz:
https://doaj.org/article/c41d711f4ff24bf8a2d40a1007a80411
Autor:
Danielle B. Rice, Swati Mehta, Janet E. Pope, Manfred Harth, Allan Shapiro, Robert W. Teasell
Publikováno v:
Pain Research and Management, Vol 2016 (2016)
Background. Patients with rheumatoid arthritis may experience increased negative outcomes if they exhibit specific patterns of dispositional affect. Objective. To identify subgroups of patients with rheumatoid arthritis based on dispositional affect.
Externí odkaz:
https://doaj.org/article/744a95d293bb4ae6accc345478d69060